Patents by Inventor Helene BOIGARD

Helene BOIGARD has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Flavivirus and alpha virus virus-like particles (VLPS)
    Patent number: 11389522
    Abstract: Flavivirus virus-like particles (VLPs) are provided that display on their surfaces antigenic flavivirus proteins. The VLPs include at least one flavivirus structural protein and at least one non-structural flavivirus protein. A DNA construct that includes sequences encoding flavivirus viral proteins used to assemble the flavivirus VLP is also provided. A method of producing flavivirus VLPs by introducing one or more the DNA constructs into a host cell is also provided. An immunogenic composition that includes the flavivirus VLP is also provided.
    Type: Grant
    Filed: September 4, 2020
    Date of Patent: July 19, 2022
    Assignee: TECHNOVAX, INC.
    Inventors: Jose M. Galarza, Helene Boigard, George Martin
  • Human respiratory syncytial virus (HRSV) virus-like particles (VLPS) based vaccine
    Patent number: 11324816
    Abstract: Described herein are virus-like particles (VLPs) that display on their surfaces antigenic paramyxovirus (e.g., RSV and/or MPV) proteins. Also described are methods of making and using these VLPs.
    Type: Grant
    Filed: August 29, 2016
    Date of Patent: May 10, 2022
    Assignee: TechnoVax, Inc.
    Inventors: Jose M. Galarza, Velasco Cimica, Hélène Boigard
  • FLAVIVIRUS AND ALPHAVIRUS VIRUS-LIKE PARTICLES (VLPS)
    Publication number: 20200397887
    Abstract: Described herein are flavivirus virus-like particles (VLPs) that display on their surfaces antigenic flavivirus proteins. Also described are methods of making and using these VLPs.
    Type: Application
    Filed: September 4, 2020
    Publication date: December 24, 2020
    Inventors: Jose M. GALARZA, Helene BOIGARD, George MARTIN
  • Flavivirus and alphavirus virus-like particles (VLPS)
    Patent number: 10799575
    Abstract: Described herein are flavivirus virus-like particles (VLPs) that display on their surfaces antigenic flavivirus proteins. Also described are methods of making and using these VLPs.
    Type: Grant
    Filed: June 23, 2016
    Date of Patent: October 13, 2020
    Assignee: TECHNOVAX, INC.
    Inventors: Jose M. Galarza, Helene Boigard, George Martin
  • HUMAN RESPIRATORY SYNCYTIAL VIRUS (HRSV) VIRUS-LIKE PARTICLES (VLPS) BASED VACCINE
    Publication number: 20190030156
    Abstract: Described herein are virus-like particles (VLPs) that display on their surfaces antigenic paramyxovirus (e.g., RSV and/or MPV) proteins. Also described are methods of making and using these VLPs.
    Type: Application
    Filed: August 29, 2016
    Publication date: January 31, 2019
    Applicant: TechnoVax, Inc.
    Inventors: Jose M. GALARZA, Velasco CIMICA, Hélène BOIGARD
  • FLAVIVIRUS AND ALPHAVIRUS VIRUS-LIKE PARTICLES (VLPS)
    Publication number: 20180177859
    Abstract: Described herein are flavivirus virus-like particles (VLPs) that display on their surfaces antigenic flavivirus proteins. Also described are methods of making and using these VLPs.
    Type: Application
    Filed: June 23, 2016
    Publication date: June 28, 2018
    Applicant: TECHNOVAX, INC.
    Inventors: Jose M. GALARZA, Helene BOIGARD, George MARTIN